{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:30:33Z","timestamp":1773660633595,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.2169\/internalmedicine.8697-21","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T22:08:55Z","timestamp":1644271735000},"page":"2905-2909","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac Dysfunction Due to Thiamine Deficiency after Hemodialysis for Biguanide-related Lactic Acidosis"],"prefix":"10.2169","volume":"61","author":[{"given":"Hiroyuki","family":"Tamaki","sequence":"first","affiliation":[{"name":"Department of Nephrology, Saiseikai Suita Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saiseikai Suita Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kachi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saiseikai Suita Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Jimura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saiseikai Suita Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bailey CJ, Turner RC. Metformin. N Engl J Med 334: 574-579, 1996.","DOI":"10.1056\/NEJM199602293340906"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65: 20-29, 2016.","DOI":"10.1016\/j.metabol.2015.10.014"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 27: 1791-1793, 2004.","DOI":"10.2337\/diacare.27.7.1791"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865, 1998.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"5","unstructured":"5. Cavallo-Perin P, Aluffi E, Estivi P, et al. The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment. Riv Eur Sci Med Famacol 11: 45-49, 1989."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Quillen DM, Kuritzky L. Type 2 diabetes management: a comprehensive clinixal review of oral medications. Compr Ther 28: 50-61, 2002.","DOI":"10.1007\/s12019-002-0042-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kajbaf F, Arnouts P, de Broe M, et al. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiol Drug Saf 22: 1027-1035, 2013.","DOI":"10.1002\/pds.3501"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shaw JS, Wilmot RL, Kilpatrick ES. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet Med 24: 1160-1163, 2007.","DOI":"10.1111\/j.1464-5491.2007.02221.x"},{"key":"9","unstructured":"9. Treatment Guide for Diabetes 2018-2019. Japan Diabetes Society, Ed. Bunkodo, Tokyo, 2018: 103."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation:lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol 52: 129-135, 2014.","DOI":"10.3109\/15563650.2013.860985"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Schwarzbeck A. Non-steroidal anti-inflammatory drugs and metformin. Lancet 352: 818, 1998.","DOI":"10.1016\/S0140-6736(05)60712-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Calello DP, Liu KD, Wiegand TJ, et al.; Extracorporeal Treatments in Poisoning Workgroup. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med 43: 1716-1730, 2015.","DOI":"10.1097\/CCM.0000000000001002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Angioi A, Cabiddu G, Conti M, et al. Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up. BMC Nephrol 19: 77, 2018.","DOI":"10.1186\/s12882-018-0875-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yeh HC, Ting IW, Tsai CW, et al. Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series. BMC Nephrol 18: 229, 2019.","DOI":"10.1186\/s12882-017-0640-4"},{"key":"15","unstructured":"15. Bar\u00f3-Serra A, Guasch-Aragay B, Mart\u00edn-Alemany N, et al. The importance of early haemodiafiltration in the treatment of lactic acidosis associated with the administration of metformin. Nefrologia 32: 664-669, 2012."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pearlman BL, Fenves AZ, Emmett M. Metformin-associated lactic acidosis. Am J Med 101: 109-110, 1996.","DOI":"10.1016\/S0002-9343(97)89422-3"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Attas M, Hanley HG, Stultz D, et al. Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation 58: 566-572, 1978.","DOI":"10.1161\/01.CIR.58.3.566"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ihara M, Ito T, Yanagihara C, Nishimura Y. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 101: 118-121, 1999.","DOI":"10.1016\/S0303-8467(99)00014-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Coveney N, Polkinghorne KR, Linehan L, Corradini A, Kerr PG. Water-soluble vitamin levels in extended hours hemodialysis. Hemodial Int 15: 30-38, 2011.","DOI":"10.1111\/j.1542-4758.2010.00505.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Velez RJ, Myers B, Guber MS. Severe acute meta-bolic acidosis (acute beriberi): an avoidable com-plication of total parenteral nutrition. J Parenter Enteral Nutr 9: 216-219, 1985.","DOI":"10.1177\/0148607185009002216"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Imamura T, Kinugawa K. Shoshin beriberi with low cardiac output and hemodynamic deterioration treated dramatically by thiamine administration. Int Heart J 56: 568-570, 2015.","DOI":"10.1536\/ihj.15-033"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6: 442-455, 2007.","DOI":"10.1016\/S1474-4422(07)70104-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Singer P, Berger MM, Van der Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 28: 387-400, 2009.","DOI":"10.1016\/j.clnu.2009.04.024"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gilligan MA. Metformin and vitamin B12 deficiency. Arch Intern Med 162: 484-485, 2002.","DOI":"10.1001\/archinte.162.4.484"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 42: 316-327, 2016.","DOI":"10.1016\/j.diabet.2016.03.008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab 61: 1754-1761, 2016.","DOI":"10.1210\/jc.2015-3754"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Alston TA. Does metformin interfere with thiamine? Arch Intern Med 163: 983, 2003.","DOI":"10.1001\/archinte.163.8.983"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/19\/61_8697-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T03:36:36Z","timestamp":1664595396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/19\/61_8697-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":27,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8697-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"article-number":"8697-21"}}